Dataset Information


Gene expression data ARID1A knockdown OE33 cells versus mock OE33 cells

ABSTRACT: A nonsense mutation in ARID1A was identified by next generation sequencing in non-dysplastic Barrett's esophagus [BE] tissue and esophageal adenocarcinoma [EAC] tissue of a patient diagnosed with EAC. Immunohistochemistry performed on an independent archival cohort demonstrated ARID1A protein loss in 0% (0/76), 4.9% (2/40), 14.3% (4/28), 16.0% (8/50), and 12.2% (12/98) of normal squamous epithelium, BE, low-, high-grade dysplasia, and EAC tissues, respectively. Enhanced cell growth, proliferation and invasion were observed upon ARID1A knockdown in EAC cells. ARID1A was knocked down in OE33 cells (Sample MS_1 and MS_3) using on-TARGET smartpool ARID1A siRNA. At the same time, OE33 cells were transfected with a non-targeting siRNA, and these experiments (Samples MS_2 and MS_4) functioned as mock controls. Cells were harvested after 48 hours and total RNA was extracted using the Rneasy kit (Qiagen) Aim Affymetrix Human PrimeView Gene Expression Array : to determine the downstream effectors of ARID1A that are likely to contribute to the oncogenic phenotype caused by ARID1A down-regulation. Two biological replicates of each condition (2x ARID1A knockdown, and 2x Mock) were used for the microarray experiment.

ORGANISM(S): Homo sapiens  

SUBMITTER: Mirte M Streppel   Anirban Maitra  Mirte Mayke Streppel 

PROVIDER: E-GEOD-38380 | ArrayExpress | 2012-05-31



Similar Datasets

2016-01-01 | S-EPMC4871520 | BioStudies
2014-01-01 | S-EPMC3805724 | BioStudies
2019-01-01 | S-EPMC6405970 | BioStudies
2014-01-01 | S-EPMC4281214 | BioStudies
1000-01-01 | S-EPMC5725031 | BioStudies
2019-01-01 | S-EPMC6404335 | BioStudies
2013-01-01 | S-EPMC3665944 | BioStudies
1000-01-01 | S-EPMC4941344 | BioStudies
2013-01-01 | S-EPMC3789153 | BioStudies
2013-01-01 | S-EPMC3739703 | BioStudies